# FDA WARNING_LETTER - LeeSar, Inc. - July 12, 2017

Source: https://www.globalkeysolutions.net/records/warning_letter/leesar-inc/53067d10-0f84-4d3d-b62d-c714eb59e79d

> FDA WARNING_LETTER for LeeSar, Inc. on July 12, 2017. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: WARNING_LETTER
- Company Name: LeeSar, Inc.
- Inspection Date: 2017-07-12
- Product Type: Drugs
- Office Name: Office of Pharmaceutical Quality

## Related Documents

- [UNTITLED_LETTER - 2022-06-17](https://www.globalkeysolutions.net/records/untitled_letter/leesar-inc/a3af623c-849a-4645-8cdf-1e4dd1cafbe2)

## Related Officers

- [Renee Alsobrook](https://www.globalkeysolutions.net/people/renee-alsobrook/2ecfa488-4a0e-46bd-af85-a5a43456f225)
- [Program Division Director](https://www.globalkeysolutions.net/people/monica-r-maxwell/e1b3373a-80b0-4023-9aea-b4ac7170c964)

Company: https://www.globalkeysolutions.net/companies/leesar-inc/f4821188-033f-452e-8c58-6e417c412753

Office: https://www.globalkeysolutions.net/offices/office-of-pharmaceutical-quality/c3303908-9657-4cd3-ae43-2458c98e8a64